Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424.SZ)
CNY 3.85
(-4.7%)
CNY 3.85
(-4.7%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.84 Billion CNY | 45.14% |
| 2022 | 1.8 Billion CNY | 16.95% |
| 2021 | 1.54 Billion CNY | 9.68% |
| 2020 | 1.4 Billion CNY | 16.86% |
| 2019 | 1.2 Billion CNY | 4.2% |
| 2018 | 1.15 Billion CNY | 17.97% |
| 2017 | 979.49 Million CNY | 19.7% |
| 2016 | 818.3 Million CNY | 26.19% |
| 2015 | 648.45 Million CNY | 18.34% |
| 2014 | 547.96 Million CNY | 13.73% |
| 2013 | 481.8 Million CNY | 4.74% |
| 2012 | 460 Million CNY | 33.03% |
| 2011 | 345.78 Million CNY | 38.74% |
| 2010 | 249.23 Million CNY | 29.72% |
| 2009 | 192.13 Million CNY | 14.04% |
| 2008 | 168.48 Million CNY | 39.82% |
| 2007 | 120.49 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 287.11 Million CNY | -12.93% |
| 2024 Q2 | 366.29 Million CNY | -49.79% |
| 2024 Q1 | 729.58 Million CNY | -43.52% |
| 2023 Q4 | 1.29 Billion CNY | 166.72% |
| 2023 FY | 2.61 Billion CNY | 45.14% |
| 2023 Q1 | 474.13 Million CNY | -31.02% |
| 2023 Q2 | 368.99 Million CNY | -22.18% |
| 2023 Q3 | 484.35 Million CNY | 31.26% |
| 2022 Q4 | 687.39 Million CNY | 30.57% |
| 2022 Q3 | 526.47 Million CNY | 78.1% |
| 2022 Q2 | 295.6 Million CNY | 0.13% |
| 2022 Q1 | 295.21 Million CNY | -47.98% |
| 2022 FY | 1.8 Billion CNY | 16.95% |
| 2021 Q2 | 296.98 Million CNY | -7.06% |
| 2021 Q3 | 359.08 Million CNY | 20.91% |
| 2021 Q1 | 319.55 Million CNY | -31.96% |
| 2021 FY | 1.54 Billion CNY | 9.68% |
| 2021 Q4 | 567.54 Million CNY | 58.05% |
| 2020 Q3 | 381.08 Million CNY | 40.35% |
| 2020 FY | 1.4 Billion CNY | 16.86% |
| 2020 Q1 | 284.73 Million CNY | -27.5% |
| 2020 Q2 | 271.52 Million CNY | -4.64% |
| 2020 Q4 | 469.65 Million CNY | 23.24% |
| 2019 Q2 | 282.27 Million CNY | 27.36% |
| 2019 FY | 1.2 Billion CNY | 4.2% |
| 2019 Q3 | 307.31 Million CNY | 8.87% |
| 2019 Q1 | 221.63 Million CNY | -44.5% |
| 2019 Q4 | 392.72 Million CNY | 27.79% |
| 2018 Q2 | 280.66 Million CNY | 42.33% |
| 2018 Q4 | 399.35 Million CNY | 43.52% |
| 2018 Q1 | 197.18 Million CNY | -31.62% |
| 2018 FY | 1.15 Billion CNY | 17.97% |
| 2018 Q3 | 278.26 Million CNY | -0.85% |
| 2017 Q4 | 288.36 Million CNY | 21.21% |
| 2017 FY | 979.49 Million CNY | 19.7% |
| 2017 Q1 | 205.53 Million CNY | -19.93% |
| 2017 Q2 | 247.7 Million CNY | 20.51% |
| 2017 Q3 | 237.89 Million CNY | -3.96% |
| 2016 Q1 | 119.08 Million CNY | -37.13% |
| 2016 Q3 | 217.7 Million CNY | -3.16% |
| 2016 FY | 818.3 Million CNY | 26.19% |
| 2016 Q2 | 224.81 Million CNY | 88.78% |
| 2016 Q4 | 256.7 Million CNY | 17.92% |
| 2015 Q4 | 189.42 Million CNY | -6.85% |
| 2015 FY | 648.45 Million CNY | 18.34% |
| 2015 Q3 | 203.36 Million CNY | 29.6% |
| 2015 Q2 | 156.91 Million CNY | 58.9% |
| 2015 Q1 | 98.75 Million CNY | -44.79% |
| 2014 Q4 | 178.86 Million CNY | 16.07% |
| 2014 Q2 | 125.39 Million CNY | 39.95% |
| 2014 Q3 | 154.1 Million CNY | 22.89% |
| 2014 FY | 547.96 Million CNY | 13.73% |
| 2014 Q1 | 89.59 Million CNY | -46.92% |
| 2013 Q4 | 168.8 Million CNY | 49.74% |
| 2013 FY | 481.8 Million CNY | 4.74% |
| 2013 Q3 | 112.73 Million CNY | 7.02% |
| 2013 Q1 | 94.93 Million CNY | -47.5% |
| 2013 Q2 | 105.33 Million CNY | 10.95% |
| 2012 Q2 | 115.12 Million CNY | 60.54% |
| 2012 FY | 460 Million CNY | 33.03% |
| 2012 Q1 | 71.71 Million CNY | -48.35% |
| 2012 Q3 | 92.33 Million CNY | -19.8% |
| 2012 Q4 | 180.83 Million CNY | 95.85% |
| 2011 FY | 345.78 Million CNY | 38.74% |
| 2011 Q4 | 138.84 Million CNY | 73.41% |
| 2011 Q1 | 44.7 Million CNY | -52.93% |
| 2011 Q2 | 82.16 Million CNY | 83.79% |
| 2011 Q3 | 80.06 Million CNY | -2.55% |
| 2010 Q4 | 94.98 Million CNY | 120.32% |
| 2010 Q2 | 60.68 Million CNY | 20.28% |
| 2010 FY | 249.23 Million CNY | 29.72% |
| 2010 Q1 | 50.45 Million CNY | -41.17% |
| 2010 Q3 | 43.11 Million CNY | -28.96% |
| 2009 Q3 | 29.38 Million CNY | -18.31% |
| 2009 FY | 192.13 Million CNY | 14.04% |
| 2009 Q4 | 85.75 Million CNY | 191.87% |
| 2009 Q1 | 41.02 Million CNY | 0.0% |
| 2009 Q2 | 35.96 Million CNY | -12.33% |
| 2008 FY | 168.48 Million CNY | 39.82% |
| 2007 FY | 120.49 Million CNY | 0.0% |